Cellex-C International Inc. – FDA Inspection, Jan 19, 2017

Record Details

This FDA Inspection record concerns Cellex-C International Inc., with an inspection on January 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Cellex-C International Inc.
Inspection Date: January 19, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Azza Talaat (FDA Associated Person)

View Company Profile

ID · 1d534443-bd99-41c0-a03a-c31cb5a8f93d

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1001314
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cellex-C International Inc.

FDA Inspection

Cellex-C International Inc.January 19, 2017